Publisher： Blackwell Publishing
E-ISSN： 1097-0142|120|23|3731-3737
ISSN： 0008-543X
Source： Cancer, Vol.120, Iss.23, 2014-12, pp. : 3731-3737
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. :
Access to resources
Recommend
Clinical benefit of lovastatin consistent across risk groups
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :
Benefit–risk assessment: the use of clinical utility index
Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. :
OCs: benefits outweigh adverse effects for cancer risk
Reactions Weekly, Vol. 1, Iss. 1121, 2006-01 ,pp. :
Benefits of thrombolytics outweigh risk in diabetic patients
Inpharma, Vol. 1, Iss. 1377, 2003-01 ,pp. :